|
|
|
|
|
|
First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus
Anita Kapur, Robin O¿Connor-Semmes, Elizabeth K Hussey, Robert L Dobbins, Wenli Tao, Marcus Hompesch, Glenn A Smith, Joseph W Polli, Charles D James Jr, Imao Mikoshiba, Derek J Nunez BMC Pharmacology and Toxicology 2013, 14:26 (13 May 2013)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Rifampicin-warfarin interaction leading to macroscopic hematuria: a case report and review of the literature
Maria AP Martins, Adriano MM Reis, Mariana F Sales, Vandack Nobre, Daniel D Ribeiro, Manoel OC Rocha, Antônio LP Ribeiro BMC Pharmacology and Toxicology 2013, 14:27 (4 May 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
|
|
|
Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus
Elizabeth K Hussey, Anita Kapur, Robin O¿Connor-Semmes, Wenli Tao, Bryan Rafferty, Joseph W Polli, Charles D James, Robert L Dobbins BMC Pharmacology and Toxicology 2013, 14:25 (30 April 2013)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Annual acknowledgement of manuscript reviewers
Christopher Morrey BMC Pharmacology and Toxicology 2013, 14:21 (29 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
|
|
|
Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa®
Urs E Gasser, Anton Fischer, Jan P Timmermans, Isabelle Arnet BMC Pharmacology and Toxicology 2013, 14:24 (23 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
|
|
|
Role of astrocytes in manganese mediated neurotoxicity
Marta Sidoryk-Wegrzynowicz, Michael Aschner BMC Pharmacology and Toxicology 2013, 14:23 (18 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
|
|
|
The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosis
Farshad Kajbaf, Jean-Daniel Lalau BMC Pharmacology and Toxicology 2013, 14:22 (12 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
|
|
|
Scottish and Newcastle Antiemetic Pre-treatment for paracetamol poisoning study (SNAP)
H K Ruben Thanacoody, Alasdair Gray, James W Dear, Judy Coyle, Euan A Sandilands, David J Webb, Steff Lewis, Michael Eddleston, Simon HL Thomas, D Nicholas Bateman BMC Pharmacology and Toxicology 2013, 14:20 (4 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
|
|
|
Cotrimoxazole plasma levels, dialyzer clearance and total removal by extended dialysis in a patient with acute kidney injury: risk of under-dosing using current dosing recommendations
Christian Clajus, W Nikolaus Kühn-Velten, Julius J Schmidt, Johan M Lorenzen, Daniel Pietsch, Gernot Beutel, Jan T Kielstein BMC Pharmacology and Toxicology 2013, 14:19 (3 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
|
|
|
Anvirzel™ in combination with cisplatin in breast, colon, lung, prostate, melanoma and pancreatic cancer cell lines
Panagiotis Apostolou, Maria Toloudi, Marina Chatziioannou, Eleni Ioannou, Dennis R Knocke, Joe Nester, Dimitrios Komiotis, Ioannis Papasotiriou BMC Pharmacology and Toxicology 2013, 14:18 (25 March 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
|
|
|
Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
Megan Morse, Haiyan Sun, Elizabeth Tran, Robert Levenson, Ye Fang BMC Pharmacology and Toxicology 2013, 14:17 (12 March 2013)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
A label-free integrative pharmacology on-target (iPOT) approach systematically surveys a library of opioid ligands against the opioid receptor family and effectively sorts them into distinct clusters based on their binding and functional selectivity.
|
|
|
|
Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal
Santosh KC, Pramote Tragulpiankit, Sarun Gorsanan, I Edwards BMC Pharmacology and Toxicology 2013, 14:16 (8 March 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Bioenergetic study of murine hepatic tissue treated in vitro with atorvastatin
Ali S Alfazari, Bayan Al-Dabbagh, Saeeda Almarzooqi, Alia Albawardi, Abdul-Kader Souid BMC Pharmacology and Toxicology 2013, 14:15 (28 February 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study
Anthony Cahn, Simon Hodgson, Robert Wilson, Jonathan Robertson, Joanna Watson, Misba Beerahee, Steve C Hughes, Graeme Young, Rebecca Graves, David Hall, Sjoerd van Marle, Roberto Solari BMC Pharmacology and Toxicology 2013, 14:14 (28 February 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
|
In utero exposure to low dose arsenic via drinking water impairs early life lung mechanics in mice
Kathryn A Ramsey, Alexander N Larcombe, Peter D Sly, Graeme R Zosky BMC Pharmacology and Toxicology 2013, 14:13 (18 February 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
Ronald G Hall, Kathleen A Hazlewood, Sara D Brouse, Christopher A Giuliano, Krystal K Haase, Chistopher R Frei, Nicolas A Forcade, Todd Bell, Roger J Bedimo, Carlos A Alvarez BMC Pharmacology and Toxicology 2013, 14:12 (13 February 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
|
3-D DNA methylation phenotypes correlate with cytotoxicity levels in prostate and liver cancer cell models
Arkadiusz Gertych, Jin Oh, Kolja A Wawrowsky, Daniel J Weisenberger, Jian Tajbakhsh BMC Pharmacology and Toxicology 2013, 14:11 (11 February 2013)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
3D quantitative DNA methylation imaging enables the quantification of dose-dependent drug-induced spatial progression of DNA demethylation in cell nuclei, independent from interphase cell-cycle stages in conjunction with cytotoxicity.
|
|
|
|
Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units
Maria Gustafsson, Stig Karlsson, Hugo Lövheim BMC Pharmacology and Toxicology 2013, 14:10 (8 February 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Effects of early life exposure to ultraviolet C radiation on mitochondrial DNA content, transcription, ATP production, and oxygen consumption in developing Caenorhabditis elegans
Maxwell CK Leung, John P Rooney, Ian T Ryde, Autumn J Bernal, Amanda S Bess, Tracey L Crocker, Alex Q Ji, Joel N Meyer BMC Pharmacology and Toxicology 2013, 14:9 (4 February 2013)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Exposure of developing Caenorhabditis elegans to ultraviolet C radiation results in decreased ATP levels and oxygen consumption in later life, suggesting that early life contact with mitochondrial genotoxicants may lead to time-delayed mitochondrial dysfunction.
|
|
|
|
Unusual case of severe arrhythmia developed after acute intoxication with tosylchloramide
Vincenzo Lariccia, Alessandra Moraca, Marco Marini, Annamaria Assunta Nasti, Ilaria Battistoni, Salvatore Amoroso, Gian Piero Perna BMC Pharmacology and Toxicology 2013, 14:8 (24 January 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin a-4 phosphate
Mohamed A Ibrahim, Diana V Do, Yasir J Sepah, Syed M Shah, Elizabeth Van Anden, Gulnar Hafiz, J Kevin Donahue, Richard Rivers, Jai Balkissoon, James T Handa, Peter A Campochiaro, Quan Dong Nguyen BMC Pharmacology and Toxicology 2013, 14:7 (14 January 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231
Mariel Núñez, Vanina Medina, Graciela Cricco, Máximo Croci, Claudia Cocca, Elena Rivera, Rosa Bergoc, Gabriela Martín BMC Pharmacology and Toxicology 2013, 14:6 (11 January 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil
Márcia Germana Alves de Araújo Lobo, Sandra Maria Botelho Pinheiro, José Gerley Díaz Castro, Valéria Gomes Momenté, Maria-Cristina S Pranchevicius BMC Pharmacology and Toxicology 2013, 14:5 (8 January 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Allosteric transition: a comparison of two models
Niels Bindslev BMC Pharmacology and Toxicology 2013, 14:4 (8 January 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Hit identification of IKKβ natural product inhibitor
Chung-Hang Leung, Daniel Shiu-Hin Chan, Ying-Wei Li, Wang-Fun Fong, Dik-Lung Ma BMC Pharmacology and Toxicology 2013, 14:3 (7 January 2013)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
A benzoic acid derivative, identified by high-throughput virtual screening and molecular modeling, is capable of inhibiting IKKβ phosphorylation activity in vitro, and blocking IκBα protein degradation together with subsequent NF-κB activation in human cells.
|